Free preview

Megaloblastic Anemia

Overview and clinical definition are open. Full Step 1 details unlock with a plan.

For the why behind the fact

Use this page to connect what you are memorizing.

Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.

Overview


Plain-Language Overview

Megaloblastic anemia is a condition that affects the blood and bone marrow, where the body produces unusually large and immature red blood cells called megaloblasts. This happens because the body lacks essential nutrients like vitamin B12 or folate, which are needed for making DNA and healthy blood cells. The main system involved is the hematologic system, and the condition leads to symptoms like fatigue, weakness, and pale skin due to reduced oxygen delivery. It can also cause neurological problems if vitamin B12 deficiency is severe. The abnormal blood cells do not function properly, leading to anemia and sometimes other complications.

Clinical Definition

Megaloblastic anemia is a type of macrocytic anemia characterized by impaired DNA synthesis resulting in ineffective hematopoiesis and the presence of large, immature nucleated red blood cells (megaloblasts) in the bone marrow. It is most commonly caused by vitamin B12 deficiency or folate deficiency, which disrupt the synthesis of thymidine and purines necessary for DNA replication. This leads to asynchronous maturation of the nucleus and cytoplasm in erythroid precursors. Clinically, it presents with macrocytic anemia, hypersegmented neutrophils, and may include neurological manifestations in vitamin B12 deficiency due to demyelination. The condition is significant because untreated deficiency can cause irreversible neurological damage and severe anemia.

Clinical Presentation


Diagnostic Workup


Pathophysiology


Treatments


Prevention


Outcome & Complications


Differential Diagnoses